Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G1B | P04054 | 1/20 | 0.44 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 7/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29234718 | 1.00 | PLA2G1B (0.44) | PLA2G1BPLA2G2ASPHK1GPR84DNM1 | |
| SCHEMBL7092733 | 1.00 | PLA2G1B (0.44) | PLA2G1BPLA2G2ASPHK1GPR84DNM1 | |
| SCHEMBL29849941 | 0.95 | PLA2G1B (0.46) | PLA2G1BPLA2G2ASPHK1GPR84DNM1 | |
| SCHEMBL25963900 | 0.93 | PLA2G1B (0.44) | PLA2G1BPLA2G2ASPHK1GPR84FFAR4 | |
| SCHEMBL25963859 | 0.93 | PLA2G1B (0.44) | PLA2G1BPLA2G2ASPHK1GPR84FFAR4 | |
| SCHEMBL25356241 | 0.93 | DNM1 (0.45) | PLA2G1BPLA2G2ASPHK1GPR84DNM1 | |
| SCHEMBL6552651 | 0.89 | PLA2G1B (0.47) | PLA2G1BPLA2G2ASPHK1GPR84DNM1 | |
| SCHEMBL29234717 | 0.87 | GPR84 (0.44) | PLA2G1BPLA2G2ASPHK1GPR84FFAR4 | |
| SCHEMBL29234705 | 0.87 | GPR84 (0.44) | PLA2G1BPLA2G2ASPHK1GPR84FFAR4 | |
| SCHEMBL3540872 | 0.87 | GPR84 (0.47) | PLA2G1BPLA2G2ASPHK1GPR84MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030166601-A1 | Novel colloid synthetic vectors for gene therapy | WOODLE MARTIN C (US) | 2003-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030166601-A1 | Novel colloid synthetic vectors for gene therapy | FUS, HNRNPUL2, HNRNPH1 | PLA2G1B 1741/4885PLA2G2A 508/4885SPHK1 3477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.